Skip to main content

Sonali Advani

Adjunct Associate Professor in the Department of Medicine
Medicine, Infectious Diseases
Hanes House Room 154, Box 102359, Durham, NC 27710

Overview


Dr. Advani is an Adjunct Associate Professor of Medicine at Duke University School of Medicine. In July 2024, she joined GSK/ViiV Healthcare as a scientific leadership physician with cross functional experience across global medical affairs as well as Research & Development in HIV therapeutics and vaccines.

Prior to this, she served as a physician investigator in the Duke Center for Antimicrobial Stewardship and Infection Prevention, a Fellow in Implementation Science at HIGH IRI (HIV, Infectious Disease and Global Health Implementation Research) Institute at Washington University, St Louis and Associate Medical Director of Infection Prevention at Yale New Haven Hospital. Her research focused on improving the diagnosis of UTIs in older adults, implementation of diagnostic stewardship interventions, and de-prescribing antibiotics for asymptomatic bacteriuria. She was awarded the K12 Urologic Career Development Award, Pepper Center Career Development Award, and SHEA Research Scholar Award to continue her UTI related research. In addition, she was one of the key investigators for CDC Prevention Epicenter Program and CDC SHEPheRD Contract for the Use of Race, Ethnicity, and Social Determinants of Health Data in NHSN Measures to Promote Health Equity.

Current Appointments & Affiliations


Adjunct Associate Professor in the Department of Medicine · 2024 - Present Medicine, Infectious Diseases, Medicine

In the News


Published July 27, 2019
Inappropriate urine culture practices contribute to overdiagnosis of CAUTIs
Published April 14, 2019
Q&A: The evolution of CAUTI and need for better metrics
Published February 19, 2019
ID WOMEN OF THE FUTURE

View All News

Recent Publications


Management of Asymptomatic Bacteriuria in Adult Female Populations.

Journal Article Obstet Gynecol Surv · December 1, 2025 (Abstracted from Urogynecology 2025;31(9):827-845) Studies have shown that antimicrobial treatment for asymptomatic bacteriuria (ASB) is not beneficial and is associated with more antibiotic resistance, infection, and longer hospital stays. As a result of ... Full text Link to item Cite

Multisociety guidance for infection prevention and control in nursing homes.

Journal Article Infect Control Hosp Epidemiol · October 28, 2025 This multisociety guidance was endorsed by SHEA, APIC, IDSA, PALTmed, and AGS. It provides recommendations for infection prevention and control (IPC) in the context of the increasing complexity of nursing home care in the United States: increased medical a ... Full text Link to item Cite

Management of Asymptomatic Bacteriuria in Adult Female Populations.

Journal Article Urogynecology (Phila) · September 1, 2025 This Clinical Consensus Statement on the management of asymptomatic bacteriuria (ASB) in adult females reflects statements drafted by content experts within the American Urogynecologic Society Bacteriuria Writing Group. The writing group created 32 clinica ... Full text Link to item Cite
View All Publications

Education, Training & Certifications


Johns Hopkins Unversity, Bloomberg School of Public Health · 2010 M.P.H.
Padmashree Dr. D. Y. Patil Medical College (India) · 2008 M.B.B.S.